Alembic Pharmaceuticals Urges Shareholders to Update KYC Details and Dematerialize Physical Shares
Alembic Pharmaceuticals Ltd has issued a reminder regarding mandatory updates for shareholders who hold company securities in physical form. The company mandates that all such security holders complete required KYC formalities and update details to ensure the timely credit of dividends or interest.The communication stresses the importance of updating PAN, Address with PIN code, Mobile Number, Bank Account details, Specimen Signature, and choosing a nomination option for shareholders holding shares in physical mode.
A key directive issued by the company is that if a security holder has not updated necessary KYC fields—including PAN or Choice of Nomination or Contact Details or Mobile Number or Bank Account Details or Specimen Signature related to their physical folios—then any dividends or interest will be withheld and released solely through electronic means.
For shareholders who complete the required updations after April 01, 2024, the company confirmed that any dividends or interest declared during the interim period (i.e., from April 01, 2024, until the date of updation) pertaining to their securities will be automatically credited to their registered bank account upon completion of these mandatory steps.
The following table outlines the status and requirements for shareholders holding physical shares:
| Field Category | Mandatory Requirement Status |
|---|---|
| PAN | Required |
| Specimen Signature | Registered (Mandatory) |
| Mobile No. | Required |
| Nominee Details | Optional |
| Email ID | Optional |
| Bank Account details | Required |
Furthermore, Alembic Pharmaceuticals reminded shareholders that the transfer of shares in physical form is not permitted as of April 1, 2019. Therefore, all shareholders holding physical securities are requested to convert their shares from physical form to demat form at the earliest possible.
The process for dematerialization involves approaching a SEBI registered depository participant (DP). Shareholders must provide the Share Certificates, Demat Request Form, Copy of PAN, Address proof, a Cancelled cheque, and any other required KYC documents. Upon submission by the shareholder to their DP, the documents are forwarded to the Registrar and Share Transfer Agent for scrutiny before the dematerialized shares are credited to the shareholder's demat account.
APLLTD Stock Price Movement
Shares of Alembic Pharmaceuticals Limited finished today with a slight upward drift, settling at ₹738.40 after gaining 0.71%. The stock saw significant intraday movement, trading between a low of ₹727.60 and a high of ₹745.45.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.